Efficacy of the GluK1/AMPA Receptor Antagonist LY293558 against Seizures and Neuropathology in a Soman-Exposure Model without Pretreatment and its Pharmacokinetics after Intramuscular Administration

Control of brain seizures after exposure to nerve agents is imperative for the prevention of brain damage and death. Animal models of nerve agent exposure make use of pretreatments, or medication administered within 1 minute after exposure, in order to prevent rapid death from peripheral toxic effec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Apland, James P., Aroniadou-Anderjaska, Vassiliki, Figueiredo, Taiza H., Green, Carol E., Swezey, Robert, Yang, Chun, Qashu, Felicia, Braga, Maria F. M.
Formato: Artigo
Lenguaje:Inglês
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2013
Materias:
Drug Discovery and Translational Medicine
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3533413/
https://ncbi.nlm.nih.gov/pubmed/23042954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.112.198689
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares